1 |
Webster L, St Marie B, McCarberg B, Passik SD, Panchal SJ, Voth E. Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain. J Opioid Manag 2011; 7: 235-45.
DOI
|
2 |
Webster LR, Cochella S, Dasgupta N, Fakata KL, Fine PG, Fishman SM, et al. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011; 12 Suppl 2: S26-35.
DOI
ScienceOn
|
3 |
Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain 2010; 11: 807-29.
DOI
ScienceOn
|
4 |
International Narcotics Control Board. The Report of the International Narcotics Control Board for 2010. Vienna, Austria, United Nations Press. 2011.
|
5 |
Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache 2011; 51 Suppl 2: 77-83.
DOI
ScienceOn
|
6 |
McCarthy LH, Bigal ME, Katz M, Derby C, Lipton RB. Chronic pain and obesity in elderly people: results from the Einstein aging study. J Am Geriatr Soc 2009; 57: 115-9.
DOI
ScienceOn
|
7 |
Mathus-Vliegen EM. Obesity and the elderly. J Clin Gastroenterol 2012; 46: 533-44.
DOI
|
8 |
Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain 2012; 13: 715-24.
DOI
ScienceOn
|
9 |
Jeffery MM, Butler M, Stark A, Kane RL. Multidisciplinary pain programs for chronic noncancer pain. Technical brief No. 8. Rockville, Agency for Healthcare Research and Quality. 2011.
|
10 |
Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986; 25: 171-86.
DOI
ScienceOn
|
11 |
The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997; 13: 6-8.
DOI
ScienceOn
|
12 |
The Federation of State Medical Boards of The United States, Inc. Model guidelines for the use of controlled substances for the treatment of pain. S D J Med 1999; 52: 25-7.
|
13 |
Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-2.
DOI
ScienceOn
|
14 |
Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K, Friedman M, et al. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain 2007; 23: 287-99.
DOI
ScienceOn
|
15 |
Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349: 1943-53.
DOI
ScienceOn
|
16 |
Papaleontiou M, Henderson CR Jr, Turner BJ, Moore AA, Olkhovskaya Y, Amanfo L, et al. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2010; 58: 1353-69.
DOI
ScienceOn
|
17 |
Carson S, Thakurta S, Low A, Smith B, Chou R. Drug class review: long-acting opioid analgesics. Portland, Oregon Evidence-based Practice Center, Oregon Health & Sciences University. 2011.
|
18 |
Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005; 7: R1046-51.
DOI
ScienceOn
|
19 |
Elliott JA, Opper SE, Agarwal S, Fibuch EE. Non-Analgesic Effects of Opioids: Opioids and The Endocrine System. Curr Pharm Des 2012 [in press].
|
20 |
Merza Z. Chronic use of opioids and the endocrine system. Horm Metab Res 2010; 42: 621-6.
DOI
ScienceOn
|
21 |
Fishman SM. Responsible opioid prescribing: a clinician's guide. 2nd ed. Washington, D.C., Waterford Life Sciences. 2012.
|
22 |
Office of National Drug Control Policy, Epidemic: responding to America's prescription drug abuse crisis. Edited by Office of National Drug Control Policy. Washington, D.C., US Government. 2011, p 10.
|
23 |
Gudin J. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice. J Pain Palliat Care Pharmacother 2012; 26: 136-43.
DOI
ScienceOn
|
24 |
Schneider JP, Matthews M, Jamison RN. Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse? CNS Drugs 2010; 24: 805-10.
DOI
ScienceOn
|
25 |
Raffa RB, Pergolizzi JV Jr. Opioid formulations designed to resist/deter abuse. Drugs 2010; 70: 1657-75.
DOI
ScienceOn
|
26 |
Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011; 14: 145-61.
|
27 |
Brack A, Rittner HL, Stein C. Immunosuppressive effects of opioids--clinical relevance. J Neuroimmune Pharmacol 2011; 6: 490-502.
DOI
|
28 |
Warner M, Chen LH, Makuc DM, Anderson RN, Minino AM. Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief 2011: 1-8.
|
29 |
Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, et al. Opioid epidemic in the United States. Pain Physician 2012; 15: ES9-38.
|
30 |
Andrews CM, Krantz MJ, Wedam EF, Marcuson MJ, Capacchione JF, Haigney MC. Methadone-induced mortality in the treatment of chronic pain: role of QT prolongation. Cardiol J 2009; 16: 210-7.
|
31 |
Committee on Advancing Pain Research, Care, and Education; Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Edited by Institute of Medicine. Washington, D.C., The National Academies Press. 2011.
|
32 |
Croft P, Blyth FM, Windt D. Chronic pain epidemiology from aetiology to public health. Oxford, Oxford University Press. 2010.
|
33 |
Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US. Drug Saf 2012; 35: 325-34.
DOI
ScienceOn
|
34 |
Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 2011; 12: 657-67.
DOI
ScienceOn
|
35 |
Colburn JL, Jasinski DR, Rastegar DA. Long-term opioid therapy, aberrant behaviors, and substance misuse: comparison of patients treated by resident and attending physicians in a general medical clinic. J Opioid Manag 2012; 8: 153-60.
DOI
ScienceOn
|
36 |
Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med 2011; 155: 325-8.
DOI
ScienceOn
|
37 |
Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC. Opioid shopping behavior: how often, how soon, which drugs, and what payment method. J Clin Pharmacol 2012 [in press].
|
38 |
Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008; 9: 444-59.
DOI
ScienceOn
|
39 |
Boscarino JA, Rukstalis MR, Hoffman SN, Han JJ, Erlich PM, Ross S, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis 2011; 30: 185-94.
DOI
ScienceOn
|
40 |
Rigg KK, Kurtz SP, Surratt HL. Patterns of prescription medication diversion among drug dealers. Drugs (Abingdon Engl) 2012; 19: 144-55.
|
41 |
Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300: 2613-20.
DOI
ScienceOn
|